LONDON (Reuters UK) - Shares in Irish drugmaker Elan ELN lost a quarter of their value on Wednesday as detailed clinical trial results for its new Alzheimer's drug bapineuzumab proved mixed, disappointing bullish investors. Researchers told the International Conference on Alzheimer's Disease in Chicago that,...
GHENT, Belgium, 21 August 2008 - Ablynx [Euronext Brussels: ABLX], apioneer in the discovery and development of Nanobodies®, a novelclass of antibody-derived therapeutic proteins, announced today thatthe Alzheimer's disease collaboration with Boehringer Ingelheim wasproceeding well and therefore the research funding has been extendedfor another year. In January 2007 Boehringer Ingelheim...
After the martyrdom of my mother, I said democracy was the best revenge - today it was proved true Benazir Bhutto's son Bilawal on the resignation of President Musharraf It is probably easier to get drugs ... round the back of the bus station...
TERRY Pratchett, who suffers from Alzheimer's disease, has condemned the NHS for failing to provide a drug, Aricept, that can dramatically improve symptoms. Pratchett, 60, known for his Discworld novels, questioned why the anti-impotence drug Viagra was available on prescription when an effective Alzheimer's drug was not....
MONDAY 18.08 The Man Who Cycled the World BBC1 10.35pm This new series documents the extraordinary tale of 24-year-old Mark Beaumont's effort to break the record for cycling 18,000 miles around the world. Chambre Hardman and the Lost City of...
WINSTON-SALEM, N.C. -- Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics[TM], today reported its financial results for the second quarter ended June 30, 2008. Targacept reported a net loss of $6.8 million for the second quarter of 2008,...
ARLINGTON, Texas, Aug. 4 /PRNewswire/ -- Since 2001, Equal Health has been providing affordable healthcare for families across the nation. Now the Arlington, Texas based company is giving us another way to protect our families. The LovePlan is a brand new insurance plan that combines critical illness...
EMERYVILLE, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTIR) , today announced it has received a quarterly royalty payment of approximately $2.1 million from Merz Pharmaceuticals GmbH Merz for sales of Memantine for the treatment of moderate-to-severe Alzheimer's disease. Under an exclusive marketing agreement, NTI currently receives...
New York State Court of Claims Late Claim Meritorious Claim Murchison v. State of New York 2008-032-108 Judge Hard Background: In this claim against the state for negligence, the claimant moves...
SAN FRANCISCO, Aug. 1 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced that David Hung, M.D., president and chief executive officer, will present at the BMO Capital Markets 2008 Focus on Healthcare Conference on Tuesday, August 5, at 11:15 a.m. Eastern Time at the Millennium Broadway Hotel in New York. ...
TORONTO, Aug. 1 /PRNewswire-FirstCall/ -- Transition Therapeutics Inc. ("Transition" or the "Company") reports today that there are no undisclosed material changes or corporate developments involving the Company to account for its recent change in stock price. About Transition ---------------- Transition is a biopharmaceutical...
*Two popular British imports have their finales this weekend. First, tonight, Doctor Who (Sci Fi, 8:30 ET/PT) ends its fourth season with an episode that finds the Torchwood folks coming to the rescue. Then on Saturday, Robin Hood (BBC America, 9 ET/PT) wraps up its second season with Robin and...
Nymox (NASDAQ:NYMX) Has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease HASBROUCK HEIGHTS, N.J. -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease AD, including for...
The Enduring Self in People with Alzheimer's Sam Fazio Health Professions Press PO Box 10624, Baltimore, MD 21285-0624 9781932529388, $26.95, www.healthpropress.com Alzheimer's is a horrible disease not to be wished on one's worst enemy. "The Enduring Self in People with...
If you are single and in your 40s, it might be a healthy idea to get hitched. A new Scandinavian study found unmarried middle-aged people are more likely to develop cognitive impairment than their partnered counterparts. But before you head to the chapel, consider a couple of caveats. "One wonders...
WEDNESDAY, July 30 HealthDay News-- New reports on very different approaches to treating Alzheimer's disease could one day lead to better therapies for the mind-robbing condition, experts say. A trio of studies that were presented Wednesday at the Alzheimer's Association 2008 International Conference on Alzheimer's Disease in Chicago noted progress...
People who tend to overthink things might be protecting themselves from Alzheimer's, according to research presented Wednesday at the International Conference on Alzheimer's Disease. A slew of studies were presented at the meeting in Chicago that looked at how certain lifestyle factors, like rumination, and family history may...
NEW YORK, July 31 /PRNewswire-FirstCall/ -- Intellect Neurosciences, Inc. (BULLETIN BOARD: ILNS) announced today it has obtained a European patent relating to the Company's ANTISENILINR monoclonal antibody platform for the treatment of Alzheimer's disease. The claims of the issued patent cover the ANTISENILINR "free-end specific" antibodies that...
Articles 2008-07-31
<< Previous
page 1 of 1
Next >>
Premier Vendor Content
Whitepapers, webcasts & resources from our Power Center Sponsors
Choose up to 5" more legroom with Economy Plus. Starting at $14.
Enjoy season-long live scoring and stats in CBSSports.com Free Fantasy Football
Innovative USB Sleep'n Charge. Stylish Fusion™ finish. Ultra-portable. It's clear why the Satellite® U405 is a smart choice for you and your small business. Only from the laptop expert, Toshiba.
